Article
FCRL4 and exhausted B cell signature in tumor infiltrating B cells from lung cancer
medRxiv · 2024 · Bryushkova, E. A.; Shchoka, E. V.; Lukyanov, D. K.; Gikalo, M. B.; Mushenkova, N.; Laktionov, K. K.; Kazakov, A. M.; Khalmurzaev, O. A.; Matveev, V. B.; Chudakov, D. M.; Serebrovskaya, E. O.
Key facts
| Title | FCRL4 and exhausted B cell signature in tumor infiltrating B cells from lung cancer |
|---|---|
| First author | Bryushkova, E. A.; Shchoka, E. V.; Lukyanov, D. K.; Gikalo, M. B.; Mushenkova, N.; Laktionov, K. K.; Kazakov, A. M.; Khalmurzaev, O. A.; Matveev, V. B.; Chudakov, D. M.; Serebrovskaya, E. O. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.11.29.626090 |
| Devices mentioned | BK110039, K010696, K073489, K073490 |
| Product codes mentioned | CFN, GKZ, MVU, PFT, JIS, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1